ArticleCurrent pharmacogenomics and personalized medicine2013

Commercial Opportunities and Ethical Pitfalls in Personalized Medicine: A Myriad of Reasons to Revisit the Myriad Genetics Saga.

Derek So et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.